Amanote Research
Register
Sign In
Human Medicines European Public Assessment Report (EPAR): NovoRapid, Insulin Aspart, Diabetes Mellitus, Date of Authorisation: 07/09/1999, Revision: 29, Status: Authorised
Case Medical Research
doi 10.31525/cmr-c3f2b2
Full Text
Open PDF
Abstract
Available in
full text
Date
August 23, 2019
Authors
Unknown
Publisher
Case Journals
Related search
Human Medicines European Public Assessment Report (EPAR): Mixtard, Insulin Human (rDNA), Diabetes Mellitus, Date of Authorisation: 07/10/2002, Revision: 18, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Ventavis, Iloprost, Hypertension, Pulmonary, Date of Authorisation: 15/09/2003, Revision: 26, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Instanyl, Fentanyl, Pain,Cancer, Date of Authorisation: 20/07/2009, Revision: 21, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Entecavir Mylan, Entecavir, Hepatitis B, Date of Authorisation: 18/09/2017, Revision: 1, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Atosiban SUN, Atosiban, Premature Birth, Date of Authorisation: 31/07/2013, Revision: 6, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Xyrem, Sodium Oxybate, Cataplexy,Narcolepsy, Date of Authorisation: 13/10/2005, Revision: 29, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Rebetol, Ribavirin, Hepatitis C, Chronic, Date of Authorisation: 06/05/1999, Revision: 32, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Raloxifene Teva, Raloxifene, Osteoporosis, Postmenopausal, Date of Authorisation: 29/04/2010, Revision: 8, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Steglujan, Ertugliflozin / Sitagliptin, Diabetes Mellitus, Type 2, Date of Authorisation: 23/03/2018, Revision: 4, Status: Authorised
Case Medical Research
